Methods for treating cell proliferative disorders and viral infections

Details for Australian Patent Application No. 2001292548 (hide)

Owner Sloan-Kettering Institute for Cancer Research

Inventors Mary, Srethapakdi; Neal, Rosen

Agent Freehills

Pub. Number AU-B-2001292548

PCT Pub. Number WO02/09696

Priority 60245264 02.11.00 US; 60221415 28.07.00 US

Filing date 27 July 2001

Wipo publication date 13 February 2002

Acceptance publication date 16 June 2005

International Classifications

A61K 031/336 - having three-membered rings, e.g. oxirane, fumagillin

A61K 031/395 - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

Event Publications

16 June 2005 Application Accepted

  Published as AU-B-2001292548

13 October 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001292549

2001292547-MEMS-BASED POLARIZATION MODE DISPERSION COMPENSATOR